This is a single group, treatment, Phase 1/Phase 2, open label, multiple cohort, first-in-human study to evaluate safety and efficacy of SAR444200 as a monotherapy or in combinatio
-
Study number:
-
NCT05450562
-
Cohorts:
-
1
-
Study phase:
-
1, 2
-
Overall status:
-
Recruiting
-
Study type:
-
Targeted therapy